Ensem Therapeutics

Ensem Therapeutics is a Boston-based biotechnology company focused on developing innovative small molecule precision medicines for oncology, with potential expansion into genetic disorders and other disease areas. They leverage their unique Kinetic Ensemble® platform to identify cryptic binding pockets of traditionally undruggable targets, accelerating structure-based drug design. This platform integrates computational and AI deep learning methodologies with advanced experimental techniques, allowing them to capture the dynamic nature of proteins and identify new opportunities for therapeutic intervention.

Ensem has assembled a world-class team of drug developers with proven track records across the continuum of R&D disciplines. They have secured significant funding, including a $67 million Series A financing led by GGV Capital. They are actively progressing their pipeline of novel drug candidates, with their lead program expected to enter clinical trials in 2024. Ensem is committed to developing transformative medicines that address high unmet medical needs and improve the lives of patients.

Ensem Therapeutics offers a generous benefits package that includes unlimited PTO, 12 paid company holidays, an end-of-year holiday shutdown, and 12 weeks of parental leave. This demonstrates a commitment to work-life balance and flexibility, encouraging employees to prioritize their well-being and personal commitments.

Ensem Therapeutics offers a comprehensive benefits package to its employees, encompassing financial, health and wellness, and time off benefits. These include competitive salary and bonus, 401(k) with a 6% match, monthly cell/internet stipend, employee referral program, life insurance, equity, medical, vision, and dental insurance covered at 90%, FSA and Dependent Care FSA plans, long- and short-term disability, an employee assistance program, an on-site fitness facility, 12 paid company holidays, end-of-year holiday shutdown, 12 weeks of parental leave, and unlimited PTO.

Ensem Therapeutics is a biotechnology company dedicated to developing innovative small molecule precision medicines for oncology. They leverage their unique Kinetic Ensemble® platform, which integrates computational and AI deep learning methodologies with advanced experimental techniques, to identify cryptic binding pockets and accelerate structure-based drug design. This allows them to focus on high-value, difficult-to-drug targets in oncology, with the ultimate goal of bringing transformative medicines to patients with unmet needs.

Ensem Therapeutics fosters a dynamic and collaborative culture that values ambition, integrity, and inclusivity. They seek individuals who are passionate about their work and driven to make a tangible impact on the lives of patients. Employees are encouraged to be bold in their thinking, embrace challenges with tenacity, and contribute to a high-performing team that prioritizes open communication and shared success. They believe in creating a work environment where everyone feels empowered to speak their minds, contribute their unique perspectives, and enjoy the journey of innovation together.

Ensem Therapeutics embraces diversity, equity, and inclusion as core values, recognizing that a diverse team fosters creativity and innovation. They strive to build an open and honest work environment where individuals feel valued and respected, and where everyone has the opportunity to speak their mind and contribute to the company's success.